Pulse Biosciences, Inc.
(NASDAQ : PLSE)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
ABTAbbott Laboratories
1.05%59.740.8%$506.91m
MDTMedtronic PLC
-0.87%80.900.6%$451.22m
ISRGIntuitive Surgical, Inc.
0.90%425.542.5%$398.43m
ALGNAlign Technology, Inc.
1.75%259.926.3%$387.41m
TMOThermo Fisher Scientific Inc.
1.63%211.221.0%$344.52m
BDXBecton, Dickinson and Company
0.96%221.941.1%$343.71m
SYKStryker Corporation
0.48%159.501.3%$249.19m
BAXBaxter International Inc.
1.15%67.811.7%$245.72m
BSXBoston Scientific Corporation
0.30%26.911.1%$231.22m
EWEdwards Lifesciences Corporation
1.04%135.711.2%$197.73m
ZBHZimmer Biomet Holdings, Inc.
1.14%120.071.7%$178.04m
XRAYDENTSPLY International Inc.
1.39%58.963.0%$144.47m
ABMDABIOMED, Inc.
0.31%271.323.3%$133.75m
VARVarian Medical Systems, Inc.
1.27%121.709.1%$131.90m
IDXXIDEXX Laboratories, Inc.
1.36%185.663.7%$125.12m

Company Profile

Pulse Biosciences, Inc. is a development stage medical device company. It manufactures surgical and medical instruments uses a novel and proprietary platform technology called Nano-Pulse Electro-Signaling. The NPES provides local tumor control and initiates an adaptive immune response with a vaccine-like effect by inducing immunogenic apoptosis of the cells. The company was founded on May 19, 2014 and is headquartered in Burlingame, CA.